Viewing Study NCT03493451


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-10 @ 6:26 PM
Study NCT ID: NCT03493451
Status: COMPLETED
Last Update Posted: 2024-10-26
First Post: 2018-04-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
Sponsor: BeiGene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T Cell Lymphoma View
None PTCL View
None Extranodal NK/T-cell Lymphoma View
None Extranodal NK/T-cell Lymphoma, Nasal Type View
None Extranodal NK T Cell Lymphoma View
None Extranodal NK T Cell Lymphoma, Nasal View
None Adult Nasal Type Extranodal NK/T-cell Lymphoma View
None Angioimmunoblastic T-cell Lymphoma View
None Angioimmunoblastic T-Cell Lymphoma Recurrent View
None Angioimmunoblastic T-Cell Lymphoma Refractory View
None Peripheral T-cell Lymphoma NOS View
None Peripheral T-Cell Lymphoma, Not Otherwise Specified View
None Peripheral T-Cell Lymphoma Refractory View
None Anaplastic Large Cell Lymphoma View
None Anaplastic Large Cell Lymphoma, ALK-Positive View
None Anaplastic Large Cell Lymphoma, ALK-negative View
None ALK-negative Anaplastic Large Cell Lymphoma View
None ALK-Positive Anaplastic Large Cell Lymphoma View
None Cutaneous T-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T/NK-cell View
None NK/T-cell View
None extranodal View
None nasal View
None NK-cell View
None ENKTL View
None peripheral T-cell View
None anaplastic large cell View
None ALCL View
None angioimmunoblastic View
None PTCL-NOS View
None Relapsed View
None Refractory View